Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapien Biosciences operates Asia’s largest hospital-linked biobank with over 300,000 patients’ samples covering more than 150 unique diseases, providing high-quality biospecimens and associated clinical data to global pharma/biotech partners. The company enables target validation, biomarker discovery/development of diagnostics—especially in oncology—and supports phenotypic drug discovery. It has established partnerships to improve the diversity of cancer datasets for AI-driven biomarker development. No therapeutic drugs are currently in clinical trials; focus remains on R&D services and diagnostic innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapien Biosciences.